Seroflo Medication Guide

Active Ingredients Composition

Seroflo contains two active ingredients: Salmeterol and Fluticasone Propionate. Salmeterol is a long-acting beta-2 agonist, which helps in relaxing muscles in the airways to improve breathing. Fluticasone Propionate is a corticosteroid that reduces inflammation in the lungs.

Mechanism of Action

Seroflo works by combining the bronchodilator effect of Salmeterol with the anti-inflammatory action of Fluticasone. Salmeterol stimulates beta-2 receptors in the bronchial muscles, leading to muscle relaxation and bronchodilation. Fluticasone inhibits multiple inflammatory pathways, including cytokines and leukotrienes, to reduce tissue inflammation.

Indications for Use

Seroflo is indicated for the chronic treatment of asthma and chronic obstructive pulmonary disease (COPD). It is used in patients who require regular treatment with both a long-acting beta agonist and an inhaled corticosteroid. It is not meant for the relief of acute bronchospasm episodes.

Dosage and Administration

Seroflo is available in multiple dosage strengths. The specific dose and frequency depend on the patient’s condition and response to treatment. Typically, it is administered via inhalation twice daily. Patients should follow their doctor’s instructions strictly and use a spacer device if recommended.

Storage Instructions

Seroflo should be stored at room temperature, away from moisture and heat. Protect the inhaler from freezing temperatures and direct sunlight. Keep the device out of reach of children, and do not puncture or burn the canister even when it appears empty.

Potential Side Effects

Common side effects of Seroflo include headache, throat irritation, hoarseness, and oral thrush. Rarely, it may cause paradoxical bronchospasm, hypokalemia, or increased blood pressure. Report any unusual symptoms to a healthcare provider promptly.

Drug Interactions

Seroflo can interact with various medications such as beta-blockers, ketoconazole, ritonavir, and other CYP3A4 inhibitors. These interactions may increase the blood levels of one or both drugs and amplify the risk of adverse effects. Inform your doctor of all medications you are taking.

Contraindications

Seroflo is contraindicated in patients with a known hypersensitivity to Salmeterol, Fluticasone, or any of the excipients. It should not be used for primary treatment of acute asthma or COPD episodes. Patients with active infections, especially fungal, should not use this medication without advice from a healthcare provider.

Monitoring Requirements

Patients using Seroflo should undergo regular monitoring of lung function, blood pressure, and ocular health. Periodic evaluations of adrenal function may also be necessary. Furthermore, routine bone density assessments are recommended in long-term use due to steroid content.

Paediatric Use

Seroflo is not recommended for children under the age of four. For pediatric patients aged four and above, dosing should be managed carefully according to healthcare provider instructions. Growth should be monitored regularly as long-term use of corticosteroids may impact growth velocity.

Pregnancy and Lactation

The safety of Seroflo in pregnant or breastfeeding women has not been established. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Caution is advised when administering to nursing women, as corticosteroids may be excreted in breast milk.

Impact on Driving

Seroflo may cause dizziness or vision disturbances in some patients. Caution is recommended when driving or operating machinery until you are confident that Seroflo does not affect your ability to perform these activities safely.

Use in Elderly Patients

Elderly patients may be more susceptible to the side effects of Seroflo, particularly osteoporosis and ocular changes like cataracts or glaucoma. Dosage adjustments may be necessary based on renal and hepatic function. Regular monitoring is essential for this age group.

Instructions for Use

Shake the inhaler well before each use. Exhale fully, place the mouthpiece in your mouth, and inhale deeply as you press the canister. Hold your breath for 10 seconds to ensure the medication reaches deep into the lungs. Rinse your mouth and throat after inhalation to minimize the risk of oral thrush and hoarseness.

Patient Counselling Points

Ensure patients understand the importance of adhering to their prescribed dosage schedule. Emphasize the correct use of the inhaler to maximize therapeutic effects. Advise regular follow-ups for dose adjustments and to monitor for side effects or efficacy.

Disposal of Inhaler

Follow local regulations for the disposal of medical waste when discarding the Seroflo inhaler. Do not throw the inhaler into open flames or incinerate it, as the canister may explode. Consult your pharmacist for proper disposal methods if you are unsure.

Clinical Trials Data

Clinical trials have demonstrated the efficacy of Seroflo in reducing the frequency of exacerbations in both asthma and COPD patients. Studies highlight improvements in lung function, reduced frequency of rescue inhaler use, and enhanced quality of life.

Pharmacokinetic Properties

Salmeterol exhibits a rapid onset of action with a typical plasma half-life of about 5.5 hours. Fluticasone Propionate has a slower onset of action but provides prolonged anti-inflammatory effects. Both components undergo extensive first-pass metabolism in the liver, primarily via the CYP3A4 enzyme system.

Renal and Hepatic Impairment

In patients with hepatic impairment, reduced metabolism of Fluticasone could lead to higher systemic exposure, necessitating dose adjustments. Renal impairment does not significantly alter the pharmacokinetics of Seroflo, but routine monitoring is recommended for safe use.